Overview

Potential for Drug-drug Interactions Between Boceprevir and Etravirine in HIV/Hepatitis C Virus Negative Volunteers

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The investigators believe that boceprevir's drug concentrations will be reduced when administered in combination with etravirine. The investigators believe that etravirine's drug concentrations will be increased when administered in combination with boceprevir. Additionally, the investigators believe that boceprevir and etravirine are safe when administered alone or in combination.
Phase:
N/A
Details
Lead Sponsor:
University of Colorado, Denver
Treatments:
Etravirine
Reverse Transcriptase Inhibitors